» Articles » PMID: 10699878

Three-dimensional Engineered Heart Tissue from Neonatal Rat Cardiac Myocytes

Overview
Publisher Wiley
Specialty Biochemistry
Date 2000 Mar 4
PMID 10699878
Citations 145
Authors
Affiliations
Soon will be listed here.
Abstract

A technique is presented that allows neonatal rat cardiac myocytes to form spontaneously and coherently beating 3-dimensional engineered heart tissue (EHT) in vitro, either as a plane biconcaval matrix anchored at both sides on Velcro-coated silicone tubes or as a ring. Contractile activity was monitored in standard organ baths or continuously in a CO(2) incubator for up to 18 days (=26 days after casting). Long-term measurements showed an increase in force between days 8 and 18 after casting and stable forces thereafter. At day 10, the twitch amplitude (TA) of electrically paced EHTs (average length x width x thickness, 11 x 6 x 0.4 mm) was 0.51 mN at length of maximal force development (L(max)) and a maximally effective calcium concentration. EHTs showed typical features of neonatal rat heart: a positive force-length and a negative force-frequency relation, high sensitivity to calcium (EC(50) 0.24 mM), modest positive inotropic (increase in TA by 46%) and pronounced positive lusitropic effect of isoprenaline (decrease in twitch duration by 21%). Both effects of isoprenaline were sensitive to the muscarinic receptor agonist carbachol in a pertussis toxin-sensitive manner. Adenovirus-mediated gene transfer of beta-galactosidase into EHTs reached 100% efficiency. In summary, EHTs retain many of the physiological characteristics of rat cardiac tissue and allow efficient gene transfer with subsequent force measurement.

Citing Articles

Bioprinting approaches in cardiac tissue engineering to reproduce blood-pumping heart function.

Kim M, Hwang D, Jang J iScience. 2025; 28(1):111664.

PMID: 39868032 PMC: 11763539. DOI: 10.1016/j.isci.2024.111664.


Current Advances and Future Directions of Pluripotent Stem Cells-Derived Engineered Heart Tissue for Treatment of Cardiovascular Diseases.

He X, Good A, Kalou W, Ahmad W, Dutta S, Chen S Cells. 2025; 13(24).

PMID: 39768189 PMC: 11674482. DOI: 10.3390/cells13242098.


Cellular and Nuclear Forces: An Overview.

Sinha B, Biswas A, Kaushik S, Soni G Methods Mol Biol. 2024; 2881():3-39.

PMID: 39704936 DOI: 10.1007/978-1-0716-4280-1_1.


Spaceflight-induced contractile and mitochondrial dysfunction in an automated heart-on-a-chip platform.

Mair D, Tsui J, Higashi T, Koenig P, Dong Z, Chen J Proc Natl Acad Sci U S A. 2024; 121(40):e2404644121.

PMID: 39312653 PMC: 11459163. DOI: 10.1073/pnas.2404644121.


Promotion of cardiac microtissue assembly within G-CSF-enriched collagen I-cardiogel hybrid hydrogel.

Khodayari H, Khodayari S, Rezaee M, Rezaeiani S, Alipour Choshali M, Erfanian S Regen Biomater. 2024; 11:rbae072.

PMID: 38974665 PMC: 11226883. DOI: 10.1093/rb/rbae072.